1.(1)patientswithliverinsufficiency;(2)patientswithuncontrolledhypertension;(3)patientswithahistoryofgastrointestinalulcer.(4)lactatingwomen.2.Enoxaparinsodiumshouldnotbemixedwithotherinjectionsorintr
1.Allergictoenoxaparinsodium.2.Patientswithacutebacterialendocarditis.3.Severeabnormalcoagulationfunction.4.Patientswithplateletdeficiencyandpositiveplateletaggregationtestinvitro.5.Allergictoheparino
1.Itismainlyusedtopreventtheformationofvenousthrombosisafterorthopedicsurgeryandgeneralsurgery,andbloodcoagulationduringextracorporealcirculationduringhemodialysis.2.Preventtheformationofdeepveinthrom
Accordingtothenorthbiggesteffectofheparinsubcutaneousinjectiontimeis3~5h,durationof24h,bioavailabilityof92%,dependingontheactivityofanticoagulantfactorsⅩa.Animalstudieshaveshownthatenoxaparinsodiumac